Chronic Lupoid Hepatitis: Autoimmune Chronic Active Hepatitis

  • Roderick N. M. MacSween


In 1950 Waldenstrom1 described a group of young female patients with chronic liver disease and marked hyperglobulinemia. Zimmerman et al.2 reported similar findings a year later. Similarly, 1 year after Joske and King3 reported the lupus erythematosus (LE) cell phenomenon in active chronic viral hepatitis, Zimmerman and colleagues4 confirmed that the LE cell phenomenon was a feature in some forms of chronic hepatic disease.


Primary Biliary Cirrhosis Chronic Active Hepatitis Smooth Muscle Antibody Chronic Active Liver Disease Chronic Hepatic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Waldenstrom J: Bluproteine und Nahrungeiweiss. Dtsch S Verdau Stoffwechselkr 2:113–119, 1950.Google Scholar
  2. 2.
    Zimmerman HJ, Heller P, Hill RP: Extreme hyperglobulinemia in subacute hepatic necrosis. S Engl J Med 244:245–249, 1951.CrossRefGoogle Scholar
  3. 3.
    Joske RA, King WE: The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet 2:477–480, 1955.CrossRefGoogle Scholar
  4. 4.
    Heller P, Zimmerman HJ, Rozengvaig MD, et al: The L.E.-cell phenomenon in chronic hepatic disease. S Engl J Med 254:1160–1165, 1956.CrossRefGoogle Scholar
  5. 5.
    Mackay IR, Taft LI, Cowling DC: Lupoid hepatitis. Lancet 2:1323–1126, 1956.CrossRefGoogle Scholar
  6. 6.
    Schaffner F: Autoimmune chronic active hepatitis: Three decades of progress. In Popper H, Schaffner F (eds): Progress in Liver Disease. Vol. VIII. Grune & Stratton, Orlando, Florida, 1986, pp. 485–503.Google Scholar
  7. 7.
    Bianchi L, Spichtin HP, Gudat F: Chronic hepatitis. In MacSween RNM, Anthony PP, Scheuer PJ (eds): Pathology of the Liver, 2nd ed. Churchill Livingstone, Edinburgh, 1987, pp. 310–341.Google Scholar
  8. 8.
    Bianchi L, De Groote J, Desmet VJ, et al: Acute and chronic hepatitis revisited. Lancet 2:914–919, 1977.Google Scholar
  9. 9.
    Kawanishi J: Morphologic association of lymphocytes with hepatocytes in chronic liver disease. Arch Pathol Lab Med 101:286–290, 1977.PubMedGoogle Scholar
  10. 10.
    Kerr JFR, Cooksley WGE, Searle J, et al: The nature of piecemeal necrosis in chronic active hepatitis. Lancet 2:827–828, 1979.PubMedCrossRefGoogle Scholar
  11. 11.
    Schaffner F, Popper H: Capillarization of hepatic sinusoids in man. Gastroenterology 44:239–242, 1963.PubMedGoogle Scholar
  12. 12.
    Bianchi FB, Biagini G, Ballardomo G, et al: Basement membrane production by hepatocytes in chronic liver disease. Hepatology 4:1167–1172, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Boyer JL, Klatsin G: Pattern of necrosis in acute viral hepatitis: Prognostic value of bridging (subacute hepatic necrosis). S Engl J Med 283:1063–171, 1970.CrossRefGoogle Scholar
  14. 14.
    Baggenstoss AH, Soloway RD, Summerskill WHJ, et al: Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. Hum Pathol 3:183–198, 1972.PubMedCrossRefGoogle Scholar
  15. 15.
    Schalm SW, Summerskill WHJ, Gitnick GL, et al: Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis S s antigen. Gut 17:781–786, 1976.PubMedCrossRefGoogle Scholar
  16. 16.
    Okuno T, Okanoue T, Takino T, et al: Prognostic significance of bridging necrosis in chronic active hepatitis. Gastroenterol Jpn 18:577–584, 1983.PubMedGoogle Scholar
  17. 17.
    Cooksley WGE, Bradbear RA, Robinson W, et al: The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 6:345–348, 1986.PubMedCrossRefGoogle Scholar
  18. 18.
    Combes B: The initial morphologic lesion in chronic hepatitis, important or unimportantS Hepatology 6:518–522, 1986.PubMedCrossRefGoogle Scholar
  19. 19.
    Good RA: Plasma-cell hepatitis and extreme hyperglobulinemia in adolescent females. Am J Dis Child 92:508–509, 1956.Google Scholar
  20. 20.
    Eggink HF, Houthoff HJ, Huitema S, et al: Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis S and primary biliary cirrhosis. Clin Exp Immunol 50:17–24, 1982.PubMedGoogle Scholar
  21. 21.
    Husby G, Blomhoff JP, Elgio K, et al: Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease. Scand J Gastroenterol 17:855–860, 1982.PubMedCrossRefGoogle Scholar
  22. 22.
    Colucci G, Colombo M, Del Ninno E, et al: In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. Gastroenterology 85:1138–1145, 1983.PubMedGoogle Scholar
  23. 23.
    Pape GR, Rieber EP, Eisenburg J, et al: Involvement of the cytotoxic /suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology 85:657–662, 1983.PubMedGoogle Scholar
  24. 24.
    Mariani E, Facchini A, Mighio F, et al: Analysis with OKT monoclonal antibodies of T-lymphocyte subsets present in blood and liver of patients with chronic active hepatitis. Liver 4:22–28, 1984.PubMedGoogle Scholar
  25. 25.
    Montano L, Aranguibel F, Boffill M, et al: An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis S virus induced chronic liver disease. Hepatology 3:292–296, 1984.CrossRefGoogle Scholar
  26. 26.
    Si L, Whiteside TL, Van Thiel DH, et al: Lymphocyte subpopulations at the site of “piecemeal” necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients. Lab Invest 50:341–347, 1984.PubMedGoogle Scholar
  27. 27.
    Frazer IH, MacKay IR, Bell J, et al: The cellular infiltrate in the liver in auto-immune chronic active hepatitis: Analysis with monoclonal antibodies. Liver 5:162–172, 1985.PubMedGoogle Scholar
  28. 28.
    Baradin KA, Desmet VJ: Interdigitating and dendritic reticulum cells in chronic active hepatitis. Histopathology 8:657–667, 1984.CrossRefGoogle Scholar
  29. 29.
    Kurki P, Gripenberg M, Teppo AM, et al: Profiles of anti-nuclear antibodies in chronic active hepatitis, biliary cirrhosis and alcoholic liver disease. Liver 4:134–138, 1984.PubMedGoogle Scholar
  30. 30.
    Davis P, Read AE: Antibodies to double stranded (native) DNA in active chronic hepatitis. Gut 16:413–415, 1975.PubMedCrossRefGoogle Scholar
  31. 31.
    Lidman K, Biberfeld G, Fagraeus A, et al: Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol 24:266–272, 1976.PubMedGoogle Scholar
  32. 32.
    Bremerton L, Brown C, Pedersen JS, et al: ELISA assay for IgG autoantibody to G-actin: Comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 51:611–616, 1983.Google Scholar
  33. 33.
    Kurki P, Miettinen A, Salaspuro, et al: Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver 3:297, 1983.Google Scholar
  34. 34.
    Rizzetto M, Swana G, Doniach D: Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 15:331–344, 1973.PubMedGoogle Scholar
  35. 35.
    Gerber MA, Shapiro JM, Smith H JS, et al: Antibodies to ribosomes in chronic active hepatitis. Gastroenterology 76:139–43, 1979.PubMedGoogle Scholar
  36. 36.
    Triger DR, Alp MH, Wright R: Bacterial and dietary antibodies in liver disease. Lancet 1:60–63, 1972.PubMedCrossRefGoogle Scholar
  37. 37.
    Triger DR, Jurtz JB, Wright R: Viral antibodies in chronic liver disease. Gut 15:94–98, 1974.PubMedCrossRefGoogle Scholar
  38. 38.
    Christie KE, Endresen C, Haukenes G: IgM antibodies in sera from patients with chronic active hepatitis with the measles virus matrix protein and nucleo-protein. J Med Virol 14:149–157, 1984.PubMedCrossRefGoogle Scholar
  39. 39.
    Roberson DAF, Zhang SL, Guy EC, et al: Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet 2:9–11, 1987.CrossRefGoogle Scholar
  40. 40.
    Jensen DM, McFarlane IG, Portman BS, et al: Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. S Engl J Med 299:1–7, 1978.CrossRefGoogle Scholar
  41. 41.
    Manns M, Meyer zum Buschenfelde K-S, Hess G: Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: Studies on organ-, species-, and disease specificity. Gut 21:955–961, 1980.PubMedCrossRefGoogle Scholar
  42. 42.
    Frazer IH, Mackay IR: Immune responses to liver-specific lipoprotein and liver membrane antigen: A tabular interpretative review. J Clin Lab Immunol 14:165–167, 1984.PubMedGoogle Scholar
  43. 43.
    Frazer IH, Jordan W, Collins EC, et al: Antibody to liver membrane antigens in chronic active hepatitis. IV. Exclusion of specific reactivity to polypeptides and glycolipids by immunoblotting. Hepatology 7:4–10, 1987.PubMedCrossRefGoogle Scholar
  44. 44.
    Jensen DM, Hall C, Majewski T: The plasma membrane origin of liver-specific protein (LSP). Liver 3:213–219, 1983.PubMedGoogle Scholar
  45. 45.
    Riisom K, Diederichsen H: Demonstration of organ-nonspecific antigens in liver-specific lipoprotein. Gastroenterology 85:1271–1276, 1983.PubMedGoogle Scholar
  46. 46.
    Murakami H, Kukiki J, Kakumu W, et al: The specificity of human liver membrane lipoprotein: Studies with monoclonal antibodies. Hepatology 4:192, 1984.PubMedCrossRefGoogle Scholar
  47. 47.
    Hopf U, Meyer zum Buschenfelde KH, Arnold W: Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. S Engl J Med 294:578–582, 1976.CrossRefGoogle Scholar
  48. 48.
    Wiedmann KH, Bartholomew TC, Brown DJC, et al: Liver membrane antibody detected by immunoradiometric assay in acute and chronic virus-induced and autoimmune liver diseases. Hepatology 4:199–204, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Roderick N. M. MacSween
    • 1
  1. 1.Department of PathologyUniversity of Glasgow and Western InfirmaryGlasgowScotland, UK

Personalised recommendations